Beverly S. Packard

3.3k total citations · 1 hit paper
17 papers, 2.5k citations indexed

About

Beverly S. Packard is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Beverly S. Packard has authored 17 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Immunology. Recurrent topics in Beverly S. Packard's work include Lipid Membrane Structure and Behavior (4 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Beverly S. Packard is often cited by papers focused on Lipid Membrane Structure and Behavior (4 papers), Immunotherapy and Immune Responses (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Beverly S. Packard collaborates with scholars based in United States, Malaysia and Thailand. Beverly S. Packard's co-authors include Paul Aebersold, Douglas J. Schwartzentruber, John P. Wei, Steven Bock, Claudia A. Seipp, Michael T. Lotze, Donald E. White, Charles W. Carter, Diane Solomon and Suzanne L. Topalian and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Beverly S. Packard

17 papers receiving 2.4k citations

Hit Papers

Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 i... 1988 2026 2000 2013 1988 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverly S. Packard United States 10 1.6k 1.5k 607 464 196 17 2.5k
Ellen Chuang United States 24 1.7k 1.1× 1.3k 0.9× 882 1.5× 266 0.6× 108 0.6× 38 3.0k
Graeme J. Dougherty United States 18 603 0.4× 472 0.3× 741 1.2× 169 0.4× 355 1.8× 44 2.0k
Shari Pilon‐Thomas United States 31 2.3k 1.5× 2.2k 1.4× 1.1k 1.9× 254 0.5× 135 0.7× 116 3.9k
Stan Lipkowitz United States 23 978 0.6× 1.2k 0.8× 1.9k 3.1× 232 0.5× 235 1.2× 29 3.0k
Jacob J. Kennedy United States 15 680 0.4× 782 0.5× 621 1.0× 301 0.6× 157 0.8× 29 1.7k
Viia Valge-Archer United Kingdom 19 1.2k 0.7× 1.0k 0.7× 1.1k 1.8× 98 0.2× 238 1.2× 27 2.4k
Markus Müschen United States 40 1.1k 0.7× 1.1k 0.7× 2.0k 3.3× 213 0.5× 150 0.8× 165 4.3k
Begonya Comin-Anduix United States 28 2.1k 1.3× 2.6k 1.7× 1.7k 2.8× 215 0.5× 140 0.7× 42 4.3k
M J Glennie United Kingdom 17 764 0.5× 578 0.4× 857 1.4× 90 0.2× 867 4.4× 25 2.2k

Countries citing papers authored by Beverly S. Packard

Since Specialization
Citations

This map shows the geographic impact of Beverly S. Packard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly S. Packard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly S. Packard more than expected).

Fields of papers citing papers by Beverly S. Packard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly S. Packard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly S. Packard. The network helps show where Beverly S. Packard may publish in the future.

Co-authorship network of co-authors of Beverly S. Packard

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly S. Packard. A scholar is included among the top collaborators of Beverly S. Packard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly S. Packard. Beverly S. Packard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hirshfield, Kim M., Dmitri Toptygin, Beverly S. Packard, & Leif Brand. (1993). Dynamic Fluorescence Measurements of Two-State Systems: Applications to Calcium-Chelating Probes. Analytical Biochemistry. 209(2). 209–218. 32 indexed citations
2.
Packard, Beverly S.. (1990). Mitogenic stimulation of human tumor-infiltrating lymphocytes by secreted factor(s) from human tumor cell lines.. Proceedings of the National Academy of Sciences. 87(11). 4058–4062. 11 indexed citations
3.
Fisher, Beth, Beverly S. Packard, E.J. Read, et al.. (1989). Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.. Journal of Clinical Oncology. 7(2). 250–261. 261 indexed citations
4.
Packard, Beverly S.. (1989). Molecular-level understanding of cytokines and tumor therapy. Trends in biotechnology. 7(4). 78–79. 1 indexed citations
5.
Read, E.J., Jorge A. Carrasquillo, James C. Yang, et al.. (1989). In Vivo Distribution of Adoptively Transferred Indium- 111- Labeled Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes in Patients With Metastatic Melanoma. JNCI Journal of the National Cancer Institute. 81(22). 1709–1717. 144 indexed citations
6.
Rosenberg, Steven A., Beverly S. Packard, Paul Aebersold, et al.. (1988). Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma. New England Journal of Medicine. 319(25). 1676–1680. 1813 indexed citations breakdown →
7.
Packard, Beverly S.. (1987). Identification of a synthetic nonapeptide sequence that inhibits motility in culture of a melanoma subclone that possesses a high metastatic potential.. Proceedings of the National Academy of Sciences. 84(24). 9015–9019. 5 indexed citations
8.
Packard, Beverly S., Michael Edidin, & Akira Komoriya. (1986). Site-directed labeling of a monoclonal antibody: targeting to a disulfide bond. Biochemistry. 25(12). 3548–3552. 13 indexed citations
9.
Packard, Beverly S.. (1986). Signal transduction through the cytoplasm. Trends in Biochemical Sciences. 11(4). 154–154. 8 indexed citations
10.
Packard, Beverly S.. (1985). Receptor phosphorylation and signal transduction across plasma membranes. Trends in Biochemical Sciences. 10(4). 138–138. 9 indexed citations
11.
Packard, Beverly S.. (1985). Modulation of receptor binding, signal transduction and connections into the cell. Trends in Biochemical Sciences. 10(10). 378–378. 2 indexed citations
12.
Packard, Beverly S. & David E. Wolf. (1985). Fluorescence lifetimes of carbocyanine lipid analogs in phospholipid bilayers. Biochemistry. 24(19). 5176–5181. 39 indexed citations
13.
Packard, Beverly S., Kerry K. Karukstis, & Melvin P. Klein. (1984). Intracellular dye heterogeneity determined by fluorescence lifetimes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 769(1). 201–208. 8 indexed citations
14.
Kikkawa, Yutaka, K Yoneda, Fred B. Smith, Beverly S. Packard, & Ken‐ichiro Suzuki. (1975). The type II epithelial cells of the lung. II. Chemical composition and phospholipid synthesis.. PubMed. 32(3). 295–302. 139 indexed citations
15.
Groves, John T. & Beverly S. Packard. (1972). Tricyclo[5.4.0.04,11]undeca-2,6,9-trien-8-one via a homobullvalenyl cation. Journal of the American Chemical Society. 94(9). 3252–3253. 12 indexed citations
16.
Lambert, Joseph B., et al.. (1971). Nitrogen inversion in cyclic N-tosylamines. The Journal of Organic Chemistry. 36(9). 1309–1310. 6 indexed citations
17.
Lambert, Joseph B., et al.. (1971). Nitrogen inversion in cyclic N-chloroamines and N-methylamines. Journal of the American Chemical Society. 93(4). 933–937. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026